Riggs Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1
| Closed | -$92 | – | 895 |
|
|
2025
Q2 | $92 | Hold |
1
| – | – | ﹤0.01% | 910 |
|
|
2025
Q1 | $114 | Hold |
1
| – | – | ﹤0.01% | 627 |
|
|
2024
Q4 | $106 | Hold |
1
| – | – | ﹤0.01% | 635 |
|
|
2024
Q3 | $108 | Hold |
1
| – | – | ﹤0.01% | 626 |
|
|
2024
Q2 | $109 | Sell |
1
-3
| -75% | -$354 | ﹤0.01% | 641 |
|
|
2024
Q1 | $528 | Buy |
4
+3
| +300% | +$375 | ﹤0.01% | 522 |
|
|
2023
Q4 | $122 | Hold |
1
| – | – | ﹤0.01% | 412 |
|
|
2023
Q3 | $113 | Hold |
1
| – | – | ﹤0.01% | 408 |
|
|
2023
Q2 | $146 | Hold |
1
| – | – | ﹤0.01% | 379 |
|
|
2023
Q1 | $130 | Hold |
1
| – | – | ﹤0.01% | 357 |
|
|
2022
Q4 | $128 | Hold |
1
| – | – | ﹤0.01% | 322 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 356 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 346 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 353 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 342 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 332 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 330 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 305 |
|
|
2020
Q4 | $0 | Buy |
+1
| New | +$141 | ﹤0.01% | 304 |
|
|
2020
Q3 | – | Sell |
-1
| Closed | – | – | 283 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 290 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 304 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 309 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 276 |
|
|
2019
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 275 |
|
|
2019
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 270 |
|
|
2018
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 259 |
|
|
2018
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 268 |
|
|
2018
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 281 |
|
|
2018
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 299 |
|
|
2017
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 292 |
|
|
2017
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 299 |
|
|
2017
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 307 |
|
|
2017
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 295 |
|
|
2016
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 292 |
|
|
2016
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 282 |
|
|
2016
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 283 |
|
|
2016
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 278 |
|
|
2015
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 281 |
|
|
2015
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 309 |
|
|
2015
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 329 |
|
|
2015
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 311 |
|
|
2014
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 316 |
|
|
2014
Q3 | $0 | Buy |
+1
| New | +$98 | ﹤0.01% | 308 |
|
Other funds holding ZBH
Riggs Asset Management's ZBH Position: Q3 2025 in Review
Riggs Asset Management sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 1 share — an estimated $92 sold.
Riggs Asset Management first reported a position in ZBH in Q3 2014 and held it in 43 quarters. The position peaked at $528 in Q1 2024. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.
- Riggs Asset Management reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
- Riggs Asset Management sold 1 Zimmer Biomet share in Q3 2025, an estimated $92.
- Riggs Asset Management first reported a position in Zimmer Biomet in Q3 2014 and held it in 43 quarters.
- Riggs Asset Management's Zimmer Biomet position peaked at $528 in Q1 2024.
- 966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.
Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.